Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
作者信息
Young J W, Inaba K
机构信息
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021, USA.
出版信息
J Exp Med. 1996 Jan 1;183(1):7-11. doi: 10.1084/jem.183.1.7.
Abstract
摘要
相似文献
1
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.树突状细胞作为I类主要组织相容性复合体限制的抗肿瘤免疫佐剂。
J Exp Med. 1996 Jan 1;183(1):7-11. doi: 10.1084/jem.183.1.7.
2
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines.
Adv Exp Med Biol. 1997;417:579-82. doi: 10.1007/978-1-4757-9966-8_93.
3
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.聚（d，l-丙交酯-共-乙交酯）纳米颗粒通过Toll样受体3诱导免疫反应用于基于树突状细胞的癌症免疫治疗
Int J Nanomedicine. 2016 Nov 2;11:5729-5742. doi: 10.2147/IJN.S109001. eCollection 2016.
4
5
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.用负载多种主要组织相容性复合体I类肽的成熟树突状细胞对转移性结直肠癌患者进行疫苗接种。
J Immunother. 2007 Oct;30(7):762-72. doi: 10.1097/CJI.0b013e318133451c.
6
Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation.实验性下调主要组织相容性复合体 I 类对肿瘤的联合免疫治疗。
Int J Mol Sci. 2018 Nov 21;19(11):3693. doi: 10.3390/ijms19113693.
7
Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.用与霍乱毒素偶联的肿瘤抗原在体外脉冲处理的树突状细胞进行疫苗接种，可有效诱导依赖树突状细胞环磷酸腺苷激活的特异性杀肿瘤CD8 + 细胞毒性淋巴细胞。
Clin Immunol. 2004 Jul;112(1):35-44. doi: 10.1016/j.clim.2004.03.001.
8
Dendritic cell-tumor cell hybrids and immunotherapy: what's next?树突状细胞-肿瘤细胞杂交瘤与免疫治疗：下一步是什么？
Cytotherapy. 2011 Aug;13(7):774-85. doi: 10.3109/14653249.2011.553593. Epub 2011 Feb 7.
9
gp96--the immune system's Swiss army knife.
Nat Immunol. 2000 Aug;1(2):100-1. doi: 10.1038/77770.
10
In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.晚期卵巢癌患者卵巢肿瘤抗原冲击的自体树突状细胞在体外诱导肿瘤特异性人类淋巴细胞抗原I类限制性CD8细胞毒性T淋巴细胞
Am J Obstet Gynecol. 2000 Sep;183(3):601-9. doi: 10.1067/mob.2000.107097.
引用本文的文献
1
Novel adjuvants & delivery vehicles for vaccines development: a road ahead.用于疫苗开发的新型佐剂和递送载体：前行之路。
Indian J Med Res. 2013 Nov;138(5):779-95.
2
Inflammation and TCR signal strength determine the breadth of the T cell response in a bim-dependent manner.炎症和 TCR 信号强度以 bim 依赖的方式决定 T 细胞反应的广度。
J Immunol. 2014 Jan 1;192(1):200-5. doi: 10.4049/jimmunol.1302289. Epub 2013 Nov 22.
3
Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.优化树突状细胞疫苗用于多发性骨髓瘤的免疫治疗：肿瘤裂解物比独特型蛋白作为肿瘤抗原更有效，能促进抗肿瘤免疫。
Clin Exp Immunol. 2012 Nov;170(2):167-77. doi: 10.1111/j.1365-2249.2012.04642.x.
4
From genes to drugs: targeted strategies for melanoma.从基因到药物：黑色素瘤的靶向治疗策略。
Nat Rev Cancer. 2012 Apr 5;12(5):349-61. doi: 10.1038/nrc3218.
5
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.通过树突状细胞/肿瘤细胞融合疫苗对细胞反应进行免疫监测。
J Biomed Biotechnol. 2011;2011:910836. doi: 10.1155/2011/910836. Epub 2011 Apr 26.
6
Regulation of tumor immunity by tumor/dendritic cell fusions.肿瘤/树突状细胞融合对肿瘤免疫的调节
Clin Dev Immunol. 2010;2010:516768. doi: 10.1155/2010/516768. Epub 2010 Oct 26.
7
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.优化树突状细胞为基础的多发性骨髓瘤免疫治疗：腔内注射针对独特型的 CD40L 成熟疫苗可诱导患者产生 1 型和细胞毒性 T 细胞免疫应答。
Br J Haematol. 2010 Sep;150(5):554-64. doi: 10.1111/j.1365-2141.2010.08286.x. Epub 2010 Jul 7.
8
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.比较 AAV/IL-7 自分泌（T 细胞）与旁分泌（DC）基因传递，以增强 CTL 刺激和功能。
Cancer Immunol Immunother. 2010 May;59(5):779-87. doi: 10.1007/s00262-009-0798-0. Epub 2009 Nov 29.
9
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses.患者来源的肾癌细胞与同种异体树突状细胞融合可引发抗肿瘤活性：体外研究结果及临床反应
Cancer Immunol Immunother. 2009 Oct;58(10):1587-97. doi: 10.1007/s00262-009-0668-9. Epub 2009 Feb 17.
10
Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells.由树突状细胞负载rAAV/GFP/IE1驱动的针对巨细胞病毒的保护性CD8 + T细胞反应。
J Transl Med. 2008 Oct 5;6:56. doi: 10.1186/1479-5876-6-56.
本文引用的文献
1
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.用肿瘤肽脉冲树突状细胞治疗小鼠肿瘤：对T细胞、B7共刺激及辅助性T细胞1相关细胞因子的依赖性
J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87.
2
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.体外负载可溶性蛋白的小鼠树突状细胞在体内可启动针对肿瘤抗原的细胞毒性T淋巴细胞。
J Exp Med. 1996 Jan 1;183(1):317-22. doi: 10.1084/jem.183.1.317.
3
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.肽脉冲树突状细胞诱导抗原特异性CTL介导的保护性肿瘤免疫。
J Exp Med. 1996 Jan 1;183(1):283-7. doi: 10.1084/jem.183.1.283.
4
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo.树突状细胞获取抗原：肠道树突状细胞获取经口服给予的抗原，并能在体内启动初始T细胞。
J Exp Med. 1993 May 1;177(5):1299-307. doi: 10.1084/jem.177.5.1299.
5
Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.粒细胞、巨噬细胞和树突状细胞源自小鼠骨髓中一种常见的主要组织相容性复合体II类阴性祖细胞。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3038-42. doi: 10.1073/pnas.90.7.3038.
6
Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.用同基因照射的、负载HIV-1包膜衍生肽的树突状细胞免疫诱导CD8 + 细胞毒性T淋巴细胞。
Int Immunol. 1993 Aug;5(8):849-57. doi: 10.1093/intimm/5.8.849.
7
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.少量超抗原呈递于树突状细胞时，足以启动T细胞应答。
J Exp Med. 1993 Aug 1;178(2):633-42. doi: 10.1084/jem.178.2.633.
8
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen.利用粒细胞/巨噬细胞集落刺激因子从正常小鼠肝脏中扩增树突状细胞祖细胞及其在Ⅰ型胶原存在下的成熟发育
J Exp Med. 1994 Jun 1;179(6):1823-34. doi: 10.1084/jem.179.6.1823.
9
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.培养的人树突状细胞对可溶性抗原的有效呈递可通过粒细胞/巨噬细胞集落刺激因子加白细胞介素4得以维持，而被肿瘤坏死因子α下调。
J Exp Med. 1994 Apr 1;179(4):1109-18. doi: 10.1084/jem.179.4.1109.
10
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.体外经肿瘤抗原脉冲处理的小鼠树突状细胞可在体内诱导肿瘤抗性。
Eur J Immunol. 1994 Mar;24(3):605-10. doi: 10.1002/eji.1830240317.
Zotero 插件